BIOGEN (DENMARK) A/S: Financial statements 2021
CVR: 21682977
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
BIOGEN (DENMARK) A/S (CVR 21682977) has filed annual accounts for 2021. In 2021, the company reported revenue of DKK 259,684,984 and a net result of DKK 7,551,843 compared with DKK 10,121,961 the year before. That is a decrease of 14.4% compared with the year before. The profit margin was 2.9%. Equity in the 2021 report amounted to DKK 122,018,771. The solvency ratio was 50.2%. The company had 22 employees in the financial year.
- Revenue
- DKK 259,684,984
- Gross Profit
- DKK 45,874,114
- Profit/Loss
- DKK 7,551,843
- Equity
- DKK 122,018,771
- Total Assets
- DKK 243,157,941
- Employees
- 22
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | 259.7 mio. | 45.9 mio. | 7.6 mio. | 122 mio. | 22 |
| 2020 | 303.4 mio. | 51.7 mio. | 10.1 mio. | 114.5 mio. | 25 |
| 2019 | 324.9 mio. | 49.6 mio. | 12.3 mio. | 104.3 mio. | 27 |
| 2018 | 355 mio. | 53.4 mio. | 12.5 mio. | 92.1 mio. | 24 |
| 2017 | 349.5 mio. | 63 mio. | 9.1 mio. | 79.5 mio. | 29 |
Official annual report
Find more companies like BIOGEN (DENMARK) A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
BIOGEN (DENMARK) A/S has published its annual report for 2020. Revenue came to DKK 303,396,452, and the net result was DKK 10,121,961.
As of June 1, 2021, Tashia Susana Lentz has joined the board of directors of BIOGEN (DENMARK) A/S.
As of June 1, 2021, Janne Harder Holmelund has left the board of directors of BIOGEN (DENMARK) A/S.
As of June 1, 2021, Tashia Susana Lentz is registered as adm. dir. of BIOGEN (DENMARK) A/S.
As of June 1, 2021, Janne Harder Holmelund has stepped down as adm. dir. of BIOGEN (DENMARK) A/S.
About BIOGEN (DENMARK) A/S
BIOGEN (DENMARK) A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 1999. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named BIOGEN IDEC (DENMARK) A/S. The management consists of Erik Magnus Bodin. The board consists of Neil Raymond Sisak (chair), Allan Frank Fischer Petersen, Erik Magnus Bodin and Sergio Ferreira da Silva Teixeira. The company is owned by Biogen Netherlands B.V.. The company has 13 employees (2026). In 2025, the company reported revenue of DKK 178,728,185 and a net result of DKK 5,563,672 compared with DKK 7,526,703 the year before. Equity in the 2025 report amounted to DKK 151,886,117.